Stock Events

Stock Events

hVIVO. 

€0.07
0
-€0.03-28.04% Today

Statistics

Day High
0.07
Day Low
0.07
52W High
0.23
52W Low
0.05
Volume
100
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.52%
Dividend
0

Upcoming

15
MAY
Dividend Ex
Estimated
 
11
JUN
Dividend Payment
Estimated
 
17
MAY 27
Dividend Ex
Estimated
 
11
JUN 27
Dividend Payment
Estimated
 
15
MAY 28
Dividend Ex
Estimated
 

Dividends

2.52%Dividend Yield
Jun 25
€0
May 24
€0
Jun 23
€0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

15AprExpected
Q2 2025
Q1 2026
0
0.34
0.67
1
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRO.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap153.59B
Pfizer is a global pharmaceutical company that competes with hVIVO in the development of vaccines and therapeutics, including those for respiratory diseases.
Merck
MRK
Mkt Cap276.38B
Merck is a leading healthcare company that develops vaccines and therapeutic drugs, competing with hVIVO in areas such as infectious disease treatment.
GSK
GSK
Mkt Cap108.66B
GlaxoSmithKline is a pharmaceutical and biotechnology company that competes with hVIVO in the development of vaccines and treatments for various diseases, including respiratory infections.
Sanofi
SNY
Mkt Cap112.08B
Sanofi is a global healthcare company that competes with hVIVO in the research and development of vaccines and treatments for infectious diseases.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson is a diversified healthcare company that competes with hVIVO in the development of drugs and vaccines, including those for infectious and respiratory diseases.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with hVIVO in the development of vaccines and treatments for various diseases, including COVID-19.
Novavax
NVAX
Mkt Cap1.34B
Novavax is a biotechnology company that focuses on the development of vaccines, directly competing with hVIVO in the vaccine development space, particularly for respiratory diseases.
BioNTech
BNTX
Mkt Cap26.67B
BioNTech is a biotechnology company that competes with hVIVO in the development of mRNA vaccines for infectious diseases, including COVID-19.
Moderna
MRNA
Mkt Cap20.12B
Moderna is a biotechnology company that specializes in mRNA technology for vaccines, competing with hVIVO in the development of vaccines for infectious diseases.

About

hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, the company offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, it provides pre­clinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company offers services to big pharma and biotech organizations. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Show more...
CEO
Dr. Yamin Mohammed Khan Ph.D.
Employees
376
Country
United Kingdom
ISIN
GB00B9275X97

Listings

STU
DE
CRO.STU
MU
DE
CRO.MU
F
DE
CRO.F
LSE
GB
HVO.LSE

0 Comments

Share your thoughts

FAQ

What is hVIVO. stock price today?▼
The current price of CRO.MU is €0.07 EUR — it has decreased by -28.04% in the past 24 hours. Watch hVIVO. stock price performance more closely on the chart.
What is hVIVO. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange hVIVO. stocks are traded under the ticker CRO.MU.
When is the next hVIVO. earnings date?▼
hVIVO. is going to release the next earnings report on September 15, 2026.
Does hVIVO. pay dividends?▼
Yes, CRO.MU dividends are paid annual. The last dividend per share was 0 EUR. As of today, Dividend Yield (FWD)% is 2.52%.
How many employees does hVIVO. have?▼
As of April 29, 2026, the company has 376 employees.
In which sector is hVIVO. located?▼
hVIVO. operates in the Other sector.
When did hVIVO. complete a stock split?▼
hVIVO. has not had any recent stock splits.
Where is hVIVO. headquartered?▼
hVIVO. is headquartered in London, United Kingdom.